SAN DIEGO — BioNano Genomics announced today a $10 million financing to support the ongoing development and commercialization of the IrysTM System for human genome analysis. Current investors, Battelle Ventures, Domain Associates, Gund Investment Corporation, participated in the financing. “BioNano Genomics has made significant progress in commercializing the Irys System first in the U.S. and […]

Billerica, Mass. —— Aushon BioSystems, a provider of multiplex immunoassay products and services, and Pacific Biomarkers, a leading provider of clinical biomarker laboratory services, have announced today that Pacific Biomarkers has adopted the Cira platform for multiplex biomarker analysis. Pacific Biomarkers will provide enhanced clinical laboratory services, including protocol consultation, sample testing, project management, data […]

SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) and NanoString Technologies, Inc. (NASDAQ:NSTG) have agreed to settle lawsuits filed by Fluidigm against NanoString. The terms of the settlement require NanoString to, among other things, remove all references – from its marketing materials, website, and promotional activities – to a single-cell comparison study comparing Fluidigm and […]

Norton, Mass. – The new Model 2304 Automated Protein Denaturation System completely automates protein stability determinations using chemical denaturation, and is both the first instrument of its kind and the first instrument to be introduced by AVIA Biosystems of Norton, Mass. (www.aviabiosystems.com). Developed to facilitate the formulation of biologics in a safe and stable form, […]

SEATTLE — NanoString Technologies, Inc. (Nasdaq:NSTG) and Fluidigm Corporation (Nasdaq:FLDM) have agreed to settle lawsuits filed by Fluidigm in the United States and Singapore. In the U.S. case, Fluidigm charged NanoString with false advertising, unfair competition, and unlawful trade practices based on a comparison study of NanoString’s Single Cell Gene Expression Assay on the nCounter® […]

OMAHA, Neb. — Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that Paul Kinnon has been named President, Chief Executive Officer and a Director, replacing Craig J. Tuttle, effective today. Mr. Kinnon brings over […]

Following last Thursday’s clearance from the German Federal Cartel Office, Endress+Hauser (Deutschland) AG+Co. KG is able to acquire the shares originally held by the Netherlands-based Verder Group, along with unsubscribed shares from the recent increase of capital stock. “Accordingly, we yesterday published the fact of having gained control over Analytik Jena, together with our decision […]

Billerica, MA — EMD Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany, accepted a Silver Stevie® Award for their Muse® Cell Analyzer and a Bronze Stevie® Award for their Direct Detect® Protein Quantitation System. These awards were distributed by the American Business AwardsSM, the premier business award program in the United States. Finalists […]

PETALUMA, CA – Biosearch Technologies, Inc. (Biosearch) is a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry. Biosearch has acquired a majority stake in LightSpeed Genomics, Inc. (LSG), a Santa Clara, California-based company developing an innovative optical detection solution for the life science and diagnostics industry based on its proprietary […]

Boulder, Colorado and Basel Switzerland — BiOptix formally announced the European expansion of the BiOptix Innovators Program at MipTec & BioValley Life Sciences Week, being held in Basel, Switzerland from September 24 – 26, 2013. During the event, the company is launching the BiOptix Innovators Program into Europe, with an emphasis on partnering with key […]